SOX9 and glioblastoma: Consistently with previous findings, the percentage of apoptotic cells was 2- to 3-fold higher in U87 and primary glioblastoma cells treated with CMPD1 (1 and 5 μM) when compared with astrocytes treated with CMPD1.